AACC 2020: Roche Panel Discusses How Pandemic Ushered In New Era For Diagnostics Ecosystem
A panel of experts, including the CEO of Roche Diagnostics, discussed how the pandemic will lead to a ”reimagining” of diagnostics, expanding access for testing with at-home testing and virtual care.
You may also be interested in...
Abbott plans to deliver 30 million BinaxNOW prescription, at-home rapid tests in the first quarter of 2021; 90 million more in the second quarter.
Roche's diagnostics division grew 3% in the first half of 2020 with exploding demand for COVID-19 tests offsetting declines in routine testing.
The company says the serology test has a specificity of 99.8% and sensitivity of 100%